Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.2.13 (
aldolase
)
3,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The preparative scale kinetic resolution of racemic aldols 1-4 using
aldolase
antibodies 38C2 (
Aldrich
no. 47995-0) and 84G3 (
Aldrich
no. 52785-8) is described. These reactions use a biphasic aqueous/organic solvent system that allows the catalyst to be reused. Reaction scales range from miligrams to grams, with 0.0086 to 0.12 mol% of antibody binding sites. Because antibodies 38C2 and 84G3 have opposite enantioselectivities, both aldol product enantiomers are accessible by kinetic resolution.
...
PMID:An efficient benchtop system for multigram-scale kinetic resolutions using aldolase antibodies. 1098 25
AN INVESTIGATION
WAS
UNDERTAKEN TO DETERMINE WHETHER ANY OF THE FOLLOWING FUNGI HAD A REQUIREMENT FOR BORON (B): Saccharomyces cerevisiae, Aspergillus niger, Neurospora crassa, and Penicillium chrysogenum. Boron was unessential, and hence a study was made of the concentrations of B that reduced the growth of S. cerevisiae and P. chrysogenum and the mode of action of the B toxicity. Fifty and 4000 mg B/liter, respectively, significantly (5% level) reduced the growth of the latter 2 species.In both, glycolysis appeared to be inhibited by toxic levels of B, since the cells accumulated fructose-1,6-diP and ADP, but were low in glyceraldehyde-3-P and ATP. With S. cerevisiae growing on glucose, 150 mg B/liter significantly reduced CO(2) evolution. When glyceraldehyde was substituted for glucose, CO(2) evolution and O(2) consumption were unaffected by this level of B.Aldolase was suspected of being inhibited by high B, and this was confirmed using a crude
aldolase
extract from S. cerevisiae and purified rabbit muscle
aldolase
. The inhibition of
aldolase
by B was uncompetitive.With
aldolase
activity being reduced by toxic levels of B, the fungi were apparently unable to utilize carbohydrates at a rate sufficient to maintain the metabolic processes involved in growth and reproduction.
...
PMID:Nonessentiality of boron in fungi and the nature of its toxicity. 1665 56
In addition to its roles in sugar metabolism, fructose-1,6-bisphosphate
aldolase
(
aldolase
) has been implicated in cellular functions independent from these roles, termed "moonlighting functions." These moonlighting functions likely involve the known
aldolase
-actin interaction, as many proteins with which
aldolase
interacts are involved in actin-dependent processes. Specifically,
aldolase
interacts both in vitro and in cells with
Wiskott-Aldrich Syndrome
Protein (WASP), a protein involved in controlling actin dynamics, yet the function of this interaction remains unknown. Here, the effect of
aldolase
on WASP-dependent processes in vitro and in cells is investigated. Aldolase inhibits WASP/Arp2/3-dependent actin polymerization in vitro. In cells, knockdown of
aldolase
results in a decreased rate of cell motility and cell spreading, two WASP-dependent processes. Expression of exogenous
aldolase
rescues these defects. Whether these effects of
aldolase
on WASP-dependent processes were due to
aldolase
catalysis or moonlighting functions is tested using
aldolase
variants defective in either catalytic or actin-binding activity. While the actin-binding deficient
aldolase
variant is unable to inhibit actin polymerization in vitro and is unable to rescue cell motility defects in cells, the catalytically inactive
aldolase
is able to perform these functions, providing evidence that
aldolase
moonlighting plays a role in WASP-mediated processes.
...
PMID:Aldolase sequesters WASP and affects WASP/Arp2/3-stimulated actin dynamics. 2349 10